42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-695289
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 4e20d167-dfb3-4809-9624-27e2eff14f38
[Document ID] => 695289
[Document naam] => Annex 7.22 RNA Pharmaceuticals Confirmation of Asset Transfer 18.09.2020 Signed.pdf.pdf
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz/document/VWS-WOO-08-695289
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-695289
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz
[DocumentPublicationDate] => 12 oktober 2020
[DocumentStatusCheckedDate] => 2026-04-28 02:15:58.50581
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 03:57:49
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 03:57:49
)
Document: VWS-WOO-08-695289
Klik om te vergroten
Document correcties
Geregistreerde datum: 20201012
Geregistreerde documentnaam: Annex 7.22 RNA Pharmaceuticals Confirmation of Asset Transfer 18.09.2020 Signed.pdf.pdf
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang publicatie_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz/file/download/inventory | 2026-03-11 04:55:56 |
| Request_Omvang publicatie_paginas | 6.725 | 2026-03-11 04:55:56 |
| Request_Omvang publicatie | 6.725 documenten waarvan 2.361 openbaar gemaakt Inventarislijst | 2026-03-11 04:55:56 |
| Request_Omvang publicatie_linkname_1 | Inventarislijst | 2026-03-11 04:55:56 |
| About_Gelakte gegevens_linkhref_2 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-09-02 08:07:35 |
| About_Gelakte gegevens | 10.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-09-02 08:07:35 |
| document_SectionDownloadButton | 1 | 2025-09-02 08:07:35 |
| About_Documentnummer | 695289 | 2025-06-22 23:36:47 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:36:47 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0005252/2018-07-28#HoofdstukV | 2025-06-22 23:36:47 |
| About_Gelakte gegevens_linkname_1 | 10.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:36:47 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-22 23:36:47 |
| document_SectionRequest | 1 | 2025-06-22 23:36:47 |
| Request_Onderdeel van | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode oktober 2020 | 2025-06-22 23:36:47 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz | 2025-06-22 23:36:47 |
| Request_Onderdeel van_linkname_1 | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode oktober 2020 | 2025-06-22 23:36:47 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 19 april 2022 een besluit genomen op verzoeken in het kader van de Wet openbaarheid van bestuur. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en medicatie over de periode oktober 2020. | 2025-06-22 23:36:47 |
| Request_Periode | Oktober 2020 | 2025-06-22 23:36:47 |
| Request_Type besluit | Wob-besluit | 2025-06-22 23:36:47 |
| Request_Datum besluit | 19 april 2022 | 2025-06-22 23:36:47 |
| document_SectionHistory | 1 | 2025-06-22 23:36:47 |
| Request_Omvang openbaarmaking_paginas | 7.928 | 2025-06-22 23:36:47 |
| document_SectionHTMLDataDivs | 3 | 2025-06-22 23:36:47 |
| document_SectionAbout | 1 | 2025-06-22 23:36:47 |
| About_Datum document | 12 oktober 2020 | 2025-06-22 23:36:47 |
| About_Type bronbestand | PDF, 2 pagina's | 2025-06-22 23:36:47 |
| About_Type bronbestand_paginas | 2 | 2025-06-22 23:36:47 |
| About_Download als | PDF (551.71 KB) | 2025-06-22 23:36:47 |
| Request_Omvang openbaarmaking | 6.724 documenten, 7.928 pagina's Inventarislijst | 2025-06-22 23:36:47 |
| Request_Omvang openbaarmaking_documenten | 6.724 | 2025-06-22 23:36:47 |
| document_documentNumber | VWS-WOO-08-695289 | 2025-06-22 23:36:47 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz/file/download/inventory | 2025-06-22 23:36:47 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:36:47 |
| document_documentName | Annex 7.22 RNA Pharmaceuticals Confirmation of Asset Transfer 18.09.2020 Signed.pdf.pdf | 2025-06-22 23:36:47 |
| document_documentType | 2025-06-22 23:36:47 | |
| document_documentPublicationDate | 2020-10-12 | 2025-06-22 23:36:47 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:36:47 |
| About_Gelakte gegevens | 10.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:36:47 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over Annex 7.22 RNA Pharmaceuticals Confirmation of Asset Transfer 18.09.2020 Signed.pdf.pdf (documentnummer 1ef8fbba-4f55-62e0-b90c-73caf8085b8d) | 2025-06-22 23:36:47 |
| History Actie_1 | Bronbestand toegevoegd (pdf, 551.71 KB) | 2025-06-21 02:54:28 |
| History Datum_1 | 21 oktober 2024 16:58 | 2025-06-21 02:54:28 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz/file/download/document/1ef8fbba-4f55-62e0-b90c-73caf8085b8d | 2025-04-19 13:25:43 |
| DocumentDownload_linkname | Download (pdf, 551.71 KB) | 2025-04-19 13:25:43 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-695289.pdf | 2025-04-19 13:25:43 |
Archiefversies (7 rijen)
Archiefrij 1 — 2025-11-21 15:37:31
fromFile: VWS-WOO-3350793-1027579-wjz-1f0a50c5-6318-6ebe-9e4e-3b248d46981f.zip
fromFilePath: archieven_files\VWS-WOO-3350793-1027579-wjz-1f0a50c5-6318-6ebe-9e4e-3b248d46981f.zip
documentName: VWS-WOO-08-695289.pdf
documentType: pdf
documentCompressedSize: 281853
documentSize: 564952
documentCompressRatio: 49.889725144791065
documentDateModified: 2025-10-09 12:38:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:37:31
lastSeen: 2025-11-21 15:37:31
text: 695289
DocuSign Envelope ID E8D5E148 970C 40E6 A618 F6E26C0F1EEE
BIONT
CH
RNA Pharmaceuticals
BioNTech RNA Pharmaceuticals GmbH
An der Goldgrube 12
•
55131 Mainz Germany
Reference number
Sierk Poetting
Contact
Department
European Commission
Call for tenders Ref SANTE 2020 C3 043
Tel
49 ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 6f7f40f84e7406f58db43a76c5ae2db54a2127552b3d818c1fd9c1e75f332c7b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: e966cf8e-b1f6-455b-b897-d884fac3f0b5
textDigestSHA256: db85e347fc5c3abf6f0ce4997a7be722a8e847e3df6ccb7372397230cf8e7309
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-695289
Archiefrij 2 — 2025-11-21 15:33:30
fromFile: VWS-WOO-3350793-1027579-wjz-1f026c98-d906-6d24-b57a-65673e0af118.zip
fromFilePath: archieven_files\VWS-WOO-3350793-1027579-wjz-1f026c98-d906-6d24-b57a-65673e0af118.zip
documentName: VWS-WOO-08-695289.pdf
documentType: pdf
documentCompressedSize: 281853
documentSize: 564952
documentCompressRatio: 49.889725144791065
documentDateModified: 2025-10-09 12:38:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:33:30
lastSeen: 2025-11-21 15:33:30
text: 695289
DocuSign Envelope ID E8D5E148 970C 40E6 A618 F6E26C0F1EEE
BIONT
CH
RNA Pharmaceuticals
BioNTech RNA Pharmaceuticals GmbH
An der Goldgrube 12
•
55131 Mainz Germany
Reference number
Sierk Poetting
Contact
Department
European Commission
Call for tenders Ref SANTE 2020 C3 043
Tel
49 ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 6f7f40f84e7406f58db43a76c5ae2db54a2127552b3d818c1fd9c1e75f332c7b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: b325e4a4-fcb4-421b-8009-423b799e4c99
textDigestSHA256: db85e347fc5c3abf6f0ce4997a7be722a8e847e3df6ccb7372397230cf8e7309
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-695289
Archiefrij 3 — 2025-09-07 17:30:27
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-695289.pdf
documentName: VWS-WOO-08-695289.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 564952
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:30:27
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:30:27
lastSeen: 2025-09-07 17:30:27
text: 695289
DocuSign Envelope IDE8D5E148 970C 40E6 A618 F6E26C0F1EEE
BIONT CH
RNA Pharmaceuticals
BioNTech RNA Pharmaceuticals GmbH
AnderGoldgrube 12•55131 Mainz Germany
Reference number
Sierk Poetting Contact
Department
European Commission
Call fortenders Ref SANTE 2020 C3043 Tel 49 0
490|102e
Fax
Email...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 6f7f40f84e7406f58db43a76c5ae2db54a2127552b3d818c1fd9c1e75f332c7b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_66915_3d0079453ea4bc308217966a13df3aa0
textDigestSHA256: 8603627388c695a7562180ba5b07e8ea6f9c9102423cf9caff58697ccaf4ad91
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-695289
Archiefrij 4 — 2025-09-04 16:20:49
fromFile: VWS-WOO-3350793-1027579-wjz-1f026c98-d906-6d24-b57a-65673e0af118.1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3350793-1027579-wjz-1f026c98-d906-6d24-b57a-65673e0af118.1.zip
documentName: VWS-WOO-08-695289.pdf
documentType: pdf
documentCompressedSize: 281853
documentSize: 564952
documentCompressRatio: 49.889725144791065
documentDateModified: 2025-05-01 20:55:36
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:20:49
lastSeen: 2025-11-21 13:47:41
text: 695289
DocuSign Envelope IDE8D5E148 970C 40E6 A618 F6E26C0F1EEE
BIONT CH
RNA Pharmaceuticals
BioNTech RNA Pharmaceuticals GmbH
AnderGoldgrube 12•55131 Mainz Germany
Reference number
Sierk Poetting Contact
Department
European Commission
Call fortenders Ref SANTE 2020 C3043 Tel 49 0
490|102e
Fax
Email...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 6f7f40f84e7406f58db43a76c5ae2db54a2127552b3d818c1fd9c1e75f332c7b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3350793-1027579-wjz-1f026c98-d906-6d24-b57a-65673e0af118.zip_14
textDigestSHA256: 8603627388c695a7562180ba5b07e8ea6f9c9102423cf9caff58697ccaf4ad91
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-695289
Archiefrij 5 — 2025-05-22 12:03:42
fromFile: VWS-WOO-3350793-1027579-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3350793-1027579-wjz.zip
documentName: VWS-WOO-08-695289.pdf
documentType: pdf
documentCompressedSize: 281853
documentSize: 564952
documentCompressRatio: 49.889725144791065
documentDateModified: 2025-05-01 20:55:36
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-05-22 12:03:42
lastSeen: 2025-05-22 12:03:42
text: 695289
DocuSign Envelope IDE8D5E148 970C 40E6 A618 F6E26C0F1EEE
BIONT CH
RNA Pharmaceuticals
BioNTech RNA Pharmaceuticals GmbH
AnderGoldgrube 12•55131 Mainz Germany
Reference number
Sierk Poetting Contact
Department
European Commission
Call fortenders Ref SANTE 2020 C3043 Tel 49 0
490|102e
Fax
Email...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 8603627388c695a7562180ba5b07e8ea6f9c9102423cf9caff58697ccaf4ad91
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 423319
textDigestSHA256: 8603627388c695a7562180ba5b07e8ea6f9c9102423cf9caff58697ccaf4ad91
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-695289
Archiefrij 6 — 2025-02-27 09:25:02
fromFile: 2023.057-VWS-WOO-3350793-1027579-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3350793-1027579-wjz.zip
documentName: VWS-WOO-08-695289-Annex_7.22_RNA_Pharmaceuticals_Confirmation_of_Asset_Transfer_18.09.2020_Signed.pdf.pdf
documentType: pdf
documentCompressedSize: 281020
documentSize: 564952
documentCompressRatio: 49.742278990073494
documentDateModified: 2024-12-05 09:39:02
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:02
lastSeen: 2025-02-27 09:25:02
text: 695289
DocuSign Envelope IDE8D5E148 970C 40E6 A618 F6E26C0F1EEE
BIONT CH
RNA Pharmaceuticals
BioNTech RNA Pharmaceuticals GmbH
AnderGoldgrube 12•55131 Mainz Germany
Reference number
Sierk Poetting Contact
Department
European Commission
Call fortenders Ref SANTE 2020 C3043 Tel 49 0
490|102e
Fax
Email...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 8603627388c695a7562180ba5b07e8ea6f9c9102423cf9caff58697ccaf4ad91
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 226485
textDigestSHA256: 8603627388c695a7562180ba5b07e8ea6f9c9102423cf9caff58697ccaf4ad91
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-695289
Archiefrij 7 — 2025-02-18 12:18:03
fromFile: Besluit__dossier_nr_-3c0952120a5d550692e659507432aada898836a9fff42682d8cc7d47fa30606c.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-3c0952120a5d550692e659507432aada898836a9fff42682d8cc7d47fa30606c.zip
documentName: VWS-WOO-08-695289-Annex_7.22_RNA_Pharmaceuticals_Confirmation_of_Asset_Transfer_18.09.2020_Signed.pdf.pdf
documentType: pdf
documentCompressedSize: 281020
documentSize: 564952
documentCompressRatio: 49.742278990073494
documentDateModified: 2024-10-21 17:14:42
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:03
lastSeen: 2025-02-18 12:18:03
text: 695289
DocuSign Envelope IDE8D5E148 970C 40E6 A618 F6E26C0F1EEE
BIONT CH
RNA Pharmaceuticals
BioNTech RNA Pharmaceuticals GmbH
AnderGoldgrube 12•55131 Mainz Germany
Reference number
Sierk Poetting Contact
Department
European Commission
Call fortenders Ref SANTE 2020 C3043 Tel 49 0
490|102e
Fax
Email...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 8603627388c695a7562180ba5b07e8ea6f9c9102423cf9caff58697ccaf4ad91
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 46566
textDigestSHA256: 8603627388c695a7562180ba5b07e8ea6f9c9102423cf9caff58697ccaf4ad91
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-695289
(dit is ook een speeltuin)